Type I

Type 1 Diabetes Diagnoses Delayed by COVID-19

The coronavirus pandemic may have delayed diabetes diagnoses for many children with type 1, according to Italian researchers studying how diabetes diagnoses in 2020 have compared to historic data. Read more

Artificial Pancreas Can Help Children as Young as Six

A new study published in the New England Journal of Medicine found that an artificial pancreas system, using a continuous glucose monitoring (CGM) device and a separate insulin pump, was safe and beneficial in children with type 1 diabetes who were as young as six years of age. Read more

Insulin Challenges for Many Amid COVID-19 Pandemic

People with diabetes are at higher risk for complications of COVID-19, and good diabetes management is key for maximizing health and reducing risk. But for many with type 1, obtaining insulin is a challenge due to job and health insurance losses in the pandemic. Read more

CGM for Pregnant Women with Type 1

For pregnant women with type 1 diabetes, their maternal glucose levels play a large role in determining fetal growth. Continuous glucose monitoring (CGM) allows expecting mothers to assess the changes in their blood glucose levels. Read more

A “Do-It-Yourself” Artificial Pancreas

Do-it-yourself artificial pancreas systems (DIYAPS) were developed by members of the diabetes community to offer a solution to type 1 diabetes patients who can’t access or afford other tech systems. Read more

AI to Help People with Type 1 Manage Glucose

Researchers have used artificial intelligence (AI) to develop an algorithm that gives people weekly guidance on managing their type 1 diabetes, based on data from a continuous glucose monitor, insulin pens, and a wearable device to monitor physical activity. The algorithm also uses a smartphone app called DailyDose. Read more

Exercising and Managing Insulin with Type 1

Balancing blood glucose levels during (and after) exercise with type 1 diabetes is key if you want to be successful at being physically active as an insulin user, and want to prevent hypoglycemia or hyperglycemia during exercise. Diabetes exercise expert Dr. Sheri Colberg shares some tips for managing insulin, food, and exercise. Read more

Preventing Type 1 May Become a Reality

Teplizumab may become the first antibody commercially available that can halt or delay the progression of type 1 diabetes. Researchers have found that a single 14-day infusion of teplizumab leads to a median 3-year delay in type 1 diabetes onset in high-risk individuals. Read more

Consumer Advocacy Group Wants SGLT-2 Warnings for Type 1 Patients

Public Citizen, a consumer advocacy group, is urging the FDA to strengthen its warnings that SGLT-2 inhibitors are associated with increased risk of diabetic ketoacidosis, due to hundreds of cases of this potentially fatal condition in people with type 1 diabetes. SGLT-2 inhibitors are not currently approved for use in type 1 diabetes in the […]

People with Type 1 at Risk for COVID-19 Complications

Researchers continue examining the relationship between diabetes and coronavirus. In a new study looking specifically at type 1 diabetes, they found that about half the people in the study with type 1 and COVID-19 had abnormally high blood sugar, which demonstrates how COVID-19 can complicate blood sugar control. Read more

AI Could Help Manage Type 1 Diabetes

Researchers at Oregon Health & Science University have developed a new method to help people with type 1 diabetes manage their glucose levels. The system uses artificial intelligence and automated monitoring, and generates recommendations that were similar to those from endocrinologists, the researchers say. Read more

Type 1 Diabetes Costs US Patients $2500 a Year, Even with Insurance

A new study found that out-of-pocket costs for Americans who have type 1 diabetes average $2,500 a year. And 8% of patients pay more than $5,000 out-of-pocket, perhaps due to high-deductible health insurance plans or significant medical needs. Insulin accounts for only 18% of this spending, with insulin pumps, syringes, CGMs and other supplies making […]

High Intensity Interval Training Shows Health Benefits for Type 1

Previous studies have shown that high intensity interval training (HIIT) improves vascular function without causing hypoglycemia, which can often be associated with moderate-intensity exercise. These studies were performed under strict supervision; a recent study sought to examine whether the benefits of HIIT would be seen in people with type 1 exercising at home. Read more

Statins and Type 1

A recent study conducted a risk assessment of cardiovascular disease, studying adherence to lipid-lowering medications in people with type 1 diabetes, to better understand how decreasing lipids could impact patients with type 1. Read more

How Does COVID-19 Affect Those with Type 1?

The Centers for Disease Control and Prevention (CDC) has noted that people with diabetes are at increased risk for severe complications if they contract COVID-19, but the agency has not addressed whether people with type 1 face different risk than those with type 2 diabetes. Now researchers are launching a study to look specifically at […]

Reversing Diabetes with Gene Editing

Scientists at Washington University announced they have developed a way to use gene editing system CRISPR-Cas9 to edit a mutation certain stem cells and then turn them into beta cells that produce insulin. When transplanted into mice, the cells reversed preexisting diabetes. Read more

Dapagliflozin for Type 1?

The European Medicines Agency has extended the indication for dapagliflozin for patients with type 1 diabetes, as well as type 2.  Still, these treatments have not been FDA approved for type 1 patients in the US. Two trials were conducted to assess how dapagliflozin performed when it was added to the medication regimen for a patient […]

Would Mass Screening Benefit Children at High Diabetes Risk?

There is currently no way to prevent type 1 diabetes, but screening trials suggest finding high-risk children early can reduce severe illness at diagnosis. Identifying children likely to develop diabetes could also speed the testing of preventive therapies. Read more

Type 1 Diabetes May be Two Distinct Conditions

New research has found that children diagnosed with type 1 diabetes under the age of seven have a different type (specifically “endotype”) of the condition compared to patients with diabetes who have been diagnosed at age thirteen or above. These findings could spur further research into whether dormant insulin-producing cells can be reactivated.  Read more

Diabetes and COVID-19

People with chronic health conditions, including diabetes, are at greater risk of developing serious complications if they contract the novel coronavirus, COVID-19. The American Diabetes Association (ADA) has guidance on what the coronavirus means for people with diabetes, and some tips on how best to protect yourself during this pandemic. Read more